Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function (REFORM-MR)
Operative Mitralklappenrekonstruktion Bei Funktionellen Mitralklappenvitien Bei Reduzierter Systolischer Ventrikelfunktion
Sponsor: Institut für Pharmakologie und Präventive Medizin
A observational or N/A phase clinical study on Left Ventricular Systolic Dysfunction and Mitral Valve Insufficiency, this trial is completed. The trial is conducted by Institut für Pharmakologie und Präventive Medizin and has accumulated 12 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jul 2023 — Oct 2023 [monthly]
Active Not Recruiting
-
Apr 2023 — Jul 2023 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2022 — Apr 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2018 — Aug 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut für Pharmakologie und Präventive Medizin
For direct contact, visit the study record on ClinicalTrials.gov .